Chemotherapy combination boosts overall survival in patients with EGFR-mutant non-small cell lung cancer

Published Date: 18 Oct 2025

In recent research, treatment with osimertinib plus a platinum–pemetrexed chemotherapy combination resulted in statistically significant and clinically meaningful improvement in overall survival in patients with newly diagnosed ...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Chemotherapy combination boosts overall survival in patients with EGFR-mutant non-small cell lung cancer

2.

Taking Charge of Your Cancer Journey.

3.

Depression risk higher among long-term breast cancer survivors than women without breast cancer history

4.

Small Renal Mass Surveillance Does Not Affect Nephron-Sparing Surgery.

5.

UK government can save lives and smash inequalities by changing prostate cancer guidelines, say experts


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot